STOCK-BASED COMPENSATION PLAN (Tables)

6 Months Ended

Jun. 30, 2026

Share-Based Payment Arrangement [Abstract]

The following table summarizes the compensation expense we recorded related to unvested stock-based awards:


	Three Months Ended				Six Months Ended
	June 30,				June 30,
(in thousands)	2026		2025		2026		2025
Cost of revenues	$	27	$	45	$	13	$	83
Selling expense	30		19		46		32
Engineering and product development expense	25		10		37		(1)
General and administrative expense	761		361		1,038		744
Total stock-based compensation expense	$	843	$	435	$	1,134	$	858

Schedule of Stock Options Valuations Assumptions

The fair value for stock options without market conditions granted were estimated at the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:


	Six Months Ended
	June 30,
	2026		2025
Risk-free interest rate	3.68	%	4.28	%
Dividend yield	0.00	%	0.00	%
Expected common stock market price volatility factor	.59		.59
Weighted average expected life of stock options (years)	6.25		6.25

Schedule of Stock Option Activity

The following table summarizes the activity related to stock options without market conditions:


Stock Options	Number of Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (yrs)	Aggregate Intrinsic Value (in thousands)
Options outstanding, January 1, 2026	876,925	$	9.85
Granted	162,021	14.47
Exercised	(330,149)	10.34
Forfeited	(106,906)	10.78
Options outstanding, June 30, 2026	601,891	$	10.66	7.9	$	4,522
Exercisable	223,897	$	10.19	6.2	$	1,789
Expected to vest	378,968	$	10.94	8.9	$	2,740

The table below summarizes certain additional information with respect to our options without market conditions:


	Three Months Ended				Six Months Ended
	June 30,				June 30,
(in thousands, except per option amounts)	2026		2025		2026		2025
Weighted average grant date fair value per option	$	—	$	—	$	8.56	$	4.61
Aggregate intrinsic value of options exercised	$	1,902	$	—	$	2,208	$	22

Schedule of Restricted Stock Awards Activity

The following table summarizes the activity related to unvested restricted stock awards:


Restricted Stock Awards	Number of Shares	Weighted Average Grant Date Fair Value
Unvested shares outstanding, January 1, 2026	149,288	$	9.67
Granted	92,264	15.11
Vested	(104,036)	10.67
Forfeited	(52,994)	11.45
Unvested shares outstanding, June 30, 2026	84,522	$	13.50

Additional information about our restricted stock awards is summarized as follows:


	Three Months Ended				Six Months Ended
	June 30,				June 30,
(in thousands)	2026		2025		2026		2025
Aggregate market value of RSA’s vested	$	225	$	94	$	1,251	$	344

The following table summarizes the activity related to unvested PSAs:


Performance-based Stock Awards	Number of Shares	Weighted Average Grant Date Fair Value
Unvested shares outstanding, January 1, 2026	100,224	$	10.58
Granted	26,264	12.65
Vested	—	—
Forfeited	(73,919)	11.72
Unvested shares outstanding, June 30, 2026	52,569	$	10.91

There were no PSAs that vested in 2026 or 2025.

We began issuing restricted stock units to certain employees in 2025. The following table summarizes the activity related to unvested restricted stock units:


Restricted Stock Units	Number of Units	Weighted Average Grant Date Fair Value
Unvested units outstanding, January 1, 2026	59,174	$	7.96
Granted	32,020	14.47
Vested	(16,306)	8.14
Forfeited	(4,382)	9.23
Unvested units outstanding, June 30, 2026	70,506	$	10.80

Additional information about our restricted stock units is summarized as follows:


	Three Months Ended				Six Months Ended
	June 30,				June 30,
(in thousands)	2026		2025		2026		2025
Aggregate market value of RSU’s vested	$	—	$	—	$	230	$	—